Sumanta Pal: Terrific Discussion Around Neoadjuvant Design in Kidney Cancer
Sumanta Pal, Vice Chair of Academic Affairs at City of Hope, shared a post on X by Uromigos, adding:
“Terrific job Brian Rini and Tom Powles.
Particularly enjoyed the discussion around neoadjuvant design. Folks, if you are planning a neoadjuvant study in kidney cancer please consider getting in touch with Axel Bex and his colleague Grant Stewart.
They have put lots of thought into study methodology and endpoints in this setting. At KCRS25, one of my favorite moments was sitting down with them Wesley Yip to hone endpoints in a study Wes is designing with his ASCO CDA.”
Quoting Uromigos’s post below:
“Introducing the IMPACT series. In these episodes, The Uromigos conduct deep dives with their peers on papers that influenced their careers, approaches to clinical care and research direction among other points of interest. In this episode Dr. Axel Bek focuses on impactful RCC trials, consolidative approaches, and what can impact an academic career.
More posts featuring Sumanta Pal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023